Comparison of dose volume histograms for supine and prone position in patients irradiated for prostate cancer-A preliminary study

Reports of Practical Oncology and Radiotherapy

Volumn 16, Issue 2, 2011, Pages 65-70

  Bajon, Tomasz ^a   Piotrowski, Tomasz ^a   Antczak, Andrzej ^b   Bąk, Bartosz ^a   Błasiak, Barbara ^a   Kaźmierska, Joanna ^a  

^a GREATER POLAND CANCER CENTRE   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Positioning; Prostate cancer; Radiotherapy; Tomotherapy

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; BLADDER; BODY POSTURE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DOSE VOLUME HISTOGRAM; HIGH RISK POPULATION; HISTOGRAM; HUMAN; IMMOBILIZATION; INTESTINE; LYMPH NODE; MALE; PARAMETER; PROSTATE CANCER; RADIATION DOSE; RECTUM; REPRODUCIBILITY; SEMINAL VESICLE; SUPINE POSITION; TREATMENT PLANNING;

EID: 79951944698     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rpor.2011.01.003     Document Type: Article

References (22)

1. D'Amico A.V., Whittington R., Malkowitcz S.B., Cote K., Loffredo M., Shultz D., et al. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era. Cancer 2002, 95:281-286.
2. Potters L., Klein E.A., Kattan M.W., Reddy C.A., Ciezki J.P., Reuther A.M., et al. Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy or permanent seed implantation. Radiother Oncol 2004, 71:29-33.
3. Kanikowski M., Skowronek J., Kubaszewska M., Chicheł A., Milecki P. Permanent implants in treatment of prostate cancer. Rep Pract Oncol Radiother 2008, 13:160-167.
4. Maciejewski B., Petrovich Z., Lange D., Borówka A. Radiotherapy for locally advanced prostate cancer: dogmas and dilemmas. Rep Pract Oncol Radiother 2003, 8:97-110.
5. Pollack A., Smith L.G., von Eschenbach A.C. External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era. Int J Radiat Oncol Biol Phys 2000, 48:507-512.
6. Valicenti R., Lu J., Pilepich M., Asbell S., Grignon D. Survival advantage from higher-dose radiation therapy for clinical localized prostate cancer treated on the radiation therapy oncology group trials. J Clin Oncol 2000, 18:2740-2746.
7. Levitt S.H., Khan F.M. The rush to judgement: does the evidence support the enthusiasm open three-dimensional conformal radiation therapy and dose escalation in the treatment of prostate cancer?. Int J Radiat Oncol Biol Phys 2001, 51:871-879.
8. Zelefsky M.J., Leibel S.A., Gaudin P.B., Kutcher G.J., Fleshner N.E., Venkatramen E.S., et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 1998, 41:491-500.
9. Bindhu J., Supe S., Pawar Y. Intensity modulated radiotherapy (IMRT) the white, black and gray: a clinical perspective. Rep Pract Oncol Radiother 2009, 14:95-103.
10. Ceylan C., Kucuk N., Ayata H.B., Guden M., Engin K. Dosimetric and physical comparison of IMRT and CyberKnife plans in the treatment of localized prostate cancer. Rep Pract Oncol Radiother 2010, 15:181-189.
11. Court L.E., D'Amico A.V., Kadam D., Cormack R. Motion and shape change when using an endorectal balloon during prostate radiation therapy. Radiother Oncol 2006, 93:131-136.
12. Smeenk R.J., Teh B.S., Butler E.B., van Lin E.N., Kaanders J.H. Is there a role for endorectal balloons in prostate radiotherapy? A systematic review. Radiother Oncol 2010, 95:277-282.
13. Zelefsky M.J., Happersett L., Leibel S.A., Burman C.M., Schwartz L., Dicker A.P., et al. The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 1997, 37(1):13-19.
14. McLaughlin P.W., Wygoda A., Sahijdak W., Sandler H.M., Marsh L., Roberson P., et al. The effect of patient position and treatment technique in conformal treatment of prostate cancer. Int J Radiat Oncol Biol Phys 1999, 45(2):407-413.
15. O'Neil L., Armstrong J., Buckney S., Assiri M., Cannon M., Holmberg O. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer. Radiother Oncol 2008, 88:61-66.
16. Baylay A.J., Catton C.N., Haycocks T., Kelly V., Alasti H., Bristow R., et al. A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer. Radiother Oncol 2003, 70:37-44.
17. Widler R.B., Chittenden L., Mesa A., Bunyapanasarn J., Agustin J., Lizarde J., et al. A prospective study of intrafraction prostate motion in the prone vs. supine position. Int J Radiat Oncol Biol Phys 2010, 77(1):165-170.
18. D'Amico A.V., Whittington R., Malkowicz S.B., Weinstein M., Tomaszewski J.E., Schultz D., et al. Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era. J Urol 2001, 166(6):2185-2188.
19. ICRU Report 50. Prescribing, recording and reporting photon beam therapy. Maryland: Bethesda; 1993.
20. ICRU Report 62. Prescribing, recording and reporting photon beam therapy (Supplement to ICRU Report 50). Maryland: Bethesda; 1999.
21. Bittner N., Butler W.M., Reed J.L., Murray B.C., Kurko B.S., Wallner K.E., et al. Electromagnetic tracking of intrafraction prostate displacement in patients externally immobilized in the prone position. Int J Radiat Oncol Biol Phys 2010, 77(2):490-495.
22. Kato T., Obata Y., Kadoya N., Fuwa N. A comparison of prone three-dimensional conformal radiotherapy with supine intensity-modulated radiotherapy for prostate cancer: which technique is more effective for rectal sparing?. Br J Radiol 2009, 82:654-661.